Photo credits: mishpacha.com
Attorney Mordechai Serle and other Jewish community activists working to make convalescent blood plasma available to treat COVID-19 patients were jolted by last week’s news: Federal health officials were holding up emergency authorization for the treatment from the US Food and Drug Administration, on the basis that data on the results was weak. But on Sunday, President Trump announced that the FDA was in fact issuing the emergency authorization after all. Serle spoke to Mishpacha about the roller-coaster news cycle and ongoing hopes that the treatment will become more widespread. Check this article released by mishpacha.com right here.